CN105687409A - 一种砭石泥灸及其制备方法 - Google Patents
一种砭石泥灸及其制备方法 Download PDFInfo
- Publication number
- CN105687409A CN105687409A CN201610093807.3A CN201610093807A CN105687409A CN 105687409 A CN105687409 A CN 105687409A CN 201610093807 A CN201610093807 A CN 201610093807A CN 105687409 A CN105687409 A CN 105687409A
- Authority
- CN
- China
- Prior art keywords
- parts
- stone needle
- radix
- chinese medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004575 stone Substances 0.000 title claims abstract description 117
- 238000000034 method Methods 0.000 title abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 82
- 239000000843 powder Substances 0.000 claims abstract description 41
- 241000628997 Flos Species 0.000 claims abstract description 40
- 244000293323 Cosmos caudatus Species 0.000 claims abstract description 21
- 235000005956 Cosmos caudatus Nutrition 0.000 claims abstract description 21
- 241000218176 Corydalis Species 0.000 claims abstract description 19
- 239000010495 camellia oil Substances 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims description 43
- 241001057584 Myrrha Species 0.000 claims description 21
- 239000003921 oil Substances 0.000 claims description 20
- 239000007766 cera flava Substances 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000011812 mixed powder Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims description 7
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 5
- 235000000484 citronellol Nutrition 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 238000009288 screen filtration Methods 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 3
- 229960002504 capsaicin Drugs 0.000 claims description 3
- 235000017663 capsaicin Nutrition 0.000 claims description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract description 36
- 208000005171 Dysmenorrhea Diseases 0.000 abstract description 31
- 239000002699 waste material Substances 0.000 abstract description 9
- 201000004624 Dermatitis Diseases 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 240000002460 Abroma augustum Species 0.000 abstract 1
- 241001287875 Boschniakia himalaica Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000492961 Diphylleia sinensis Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000220317 Rosa Species 0.000 abstract 1
- 241001118150 Triumfetta pilosa Species 0.000 abstract 1
- 241000301400 Trogopterus Species 0.000 abstract 1
- 235000013871 bee wax Nutrition 0.000 abstract 1
- 239000012166 beeswax Substances 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 229940007559 goose grease Drugs 0.000 abstract 1
- 239000000341 volatile oil Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 45
- 210000004369 blood Anatomy 0.000 description 43
- 230000000694 effects Effects 0.000 description 43
- 208000002193 Pain Diseases 0.000 description 30
- 230000036407 pain Effects 0.000 description 30
- 230000001737 promoting effect Effects 0.000 description 27
- 208000024891 symptom Diseases 0.000 description 24
- 230000017531 blood circulation Effects 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 201000010099 disease Diseases 0.000 description 14
- 230000001105 regulatory effect Effects 0.000 description 11
- 229910052712 strontium Inorganic materials 0.000 description 10
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 10
- 208000019255 Menstrual disease Diseases 0.000 description 9
- 208000010668 atopic eczema Diseases 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 7
- 230000000172 allergic effect Effects 0.000 description 7
- 230000002175 menstrual effect Effects 0.000 description 7
- 206010000087 Abdominal pain upper Diseases 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 206010070834 Sensitisation Diseases 0.000 description 6
- 229930014669 anthocyanidin Natural products 0.000 description 6
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 6
- 235000008758 anthocyanidins Nutrition 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 230000008602 contraction Effects 0.000 description 6
- 230000003179 granulation Effects 0.000 description 6
- 238000005469 granulation Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 230000008313 sensitization Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 206010063409 Acarodermatitis Diseases 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 5
- 241000447727 Scabies Species 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 208000005687 scabies Diseases 0.000 description 5
- 208000002881 Colic Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 238000009169 immunotherapy Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000003821 menstrual periods Effects 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000004080 punching Methods 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000001139 anti-pruritic effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 125000000300 citronellol group Chemical group 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229940031439 squalene Drugs 0.000 description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000002301 combined effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 208000030208 low-grade fever Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 210000004914 menses Anatomy 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000002464 muscle smooth vascular Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000027758 ovulation cycle Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 229910052683 pyrite Inorganic materials 0.000 description 2
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 2
- 239000011028 pyrite Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000001020 rhythmical effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000036560 skin regeneration Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical group CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229930185884 camellianin Natural products 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000020470 nervous system symptom Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000191 radiation effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/06—Devices for heating or cooling such points within cell-life limits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/264—Aristolochia (Dutchman's pipe)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Rehabilitation Therapy (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种砭石泥灸及其制备方法,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物25%~35%,蜂蜡10%~15%,白鹅膏10%~15%,山茶油2%~4%,玫瑰精油0.5%~1.5%,药物发热剂1.5%~3%,医用渗透剂1.5%~3%,余量为砭石粉;制成所述中药提取液物的原料组成为:延胡索、丹参、鸡血藤、炮山甲、五灵脂、红花、艾叶、天仙藤、没药、马齿苋鲜品、乌梢蛇、珍珠、白鲜皮、地肤子、紫苏叶鲜品、金纳香、窝儿七、昂天莲鲜根、枇杷芋、炙甘草。该泥灸以砭石下脚料制成的砭石粉代替火山泥成分,配合针对性治疗痛经的中药提取物,可安全有效治疗痛经,防止皮肤过敏,同时可以合理的利用砭石废料,变废为宝。
Description
技术领域
本发明涉及一种泥灸,具体涉及一种砭石泥灸及其制备方法。
背景技术
痛经为最常见的妇科症状之一,指行经前后或月经期出现下腹部疼痛、坠胀,伴有腰酸或其他不适,症状严重影响生活质量者。痛经分为原发性痛经和继发性两类,原发性痛经指生殖器官无器质性病变的痛经,占痛经90%以上;继发性痛经指由盆腔器质性疾病引起的痛经。对于症状较为严重的痛经患者,往往需要服用止痛药,如芬必得、消炎痛等,目的是减少前列腺素的分泌,但西药有明显的副作用,会引起消化道反应和中枢神经系统症状,极少的还会引起支气管痉挛和暂时肾功能损害。
对痛经来说,止痛仅仅是对症治疗,起不到预防和根治的作用。中医学认为痛经多有情志所伤、起居不慎或六淫为害等不同病因,并与素体及经期、经期前后特殊的生理环境有关。其病机主要是在此期间受到致病因素的影响,导致冲任瘀阻或寒凝经脉,使气血运行不畅,胞宫经血流通受碍,以致“不通则痛”,或冲任、胞宫失于濡养,不荣而痛.其病位在冲任、胞宫,变化在气血,表现为痛佂。其所以随月经周期发作,是与经期冲任气血变化有关。采用中药泥灸疗法调理气血是较为理想的痛经治疗手段,中药泥灸是药灸疗法以及温敷疗法相结合的一种延伸产品,其涵义是热灼、熨烫、药物疗效和穴位刺激。现有的中药泥灸是在外敷疗法的基础上加上火山能量泥、膏药基质配置而成的,利用天然岩矿火山能量泥的热辐射作用促进中草药有效成分的透皮吸收以达到治疗效果。如中国专利《一种人体外用热敷泥灸及其使用方法》(CN101897838B)公开了一种治疗骨关节病痛的中药泥灸,该产品利用矿物质能量白、黄、绿、红、黑泥粉配合中药有效成分以达到祛风散寒、活血化瘀的效果,但是这种泥灸配方较为复杂,需采用火山泥与其他4种矿物泥按比例调配才能达到热辐射和提供所需微量元素的作用,配置过程相对复杂。现有的泥灸产品多数为针对性治疗风湿骨病,少有针对性治疗妇科痛经的泥灸产品,同时中药泥灸长时间涂敷于皮肤上会造成局部皮肤温度高、湿度大,代谢废物不能排出,就会刺激局部皮肤,容易产生瘙痒、红肿等不适过敏症状。
砭石是除了火山泥外另一种具有奇特作用的能量石,砭石,即能治病的石头,最早出现在《黄帝内经》中,砭石中又以泗水砭石疗效为最佳,泗水砭石仅分布在泗水县南部山区部分地区,属于珍贵的非可再生矿石资源,用现代医学手段检测,泗滨砭石可以发出许多对人体有益的远红外射线和超声波脉冲,促进微循环、调理新陈代谢,常被用于制作刮痧板等医疗器具,然而在制备器具的过程中会产生大量的砭石废料,这些边角料很难再加以利用,会造成大量的资源浪费。
发明内容
本发明目的在于弥补现有技术不足,提供一种砭石泥灸及其制备方法,该泥灸以砭石下脚料制成的砭石粉代替火山泥成分,配合针对性治疗痛经的中药提取物,可起到安全有效治疗痛经的作用,有效防止皮肤敏感症状,同时可以合理的利用砭石废料,变废为宝。
为了实现上述目的,本发明提供的技术方案如下:
一种砭石泥灸,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物25%~35%,蜂蜡10%~15%,白鹅膏10%~15%,山茶油2%~4%,玫瑰精油0.5%~1.5%,药物发热剂1.5%~3%,医用渗透剂1.5%~3%,余量为砭石粉;制成所述中药提取液物的原料组成及重量份数为:延胡索9-15份,丹参6-8份,鸡血藤6-9份,炮山甲6-9份,五灵脂4-6份,红花9-12份,艾叶10-15份,天仙藤8-11份,没药8-12份,马齿苋鲜品10-15份,乌梢蛇5-8份,珍珠8-12份,白鲜皮9-12份,地肤子7-10份,紫苏叶鲜品10-15份,金纳香4-6份,窝儿七3-5份,昂天莲鲜根10-15份,枇杷芋2-4份,炙甘草9-12份。
进一步的,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物25%,蜂蜡10%,白鹅膏10%,山茶油2%,玫瑰精油0.5%,药物发热剂1.5%,医用渗透剂1.5%,砭石粉49.5%;制成所述中药提取液物的原料组成及重量份数为:延胡索9份,丹参6份,鸡血藤6份,炮山甲6份,五灵脂4份,红花9份,艾叶10份,天仙藤8份,没药8份,马齿苋鲜品10份,乌梢蛇5份,珍珠8份,白鲜皮9份,地肤子7份,紫苏叶鲜品10份,金纳香4份,窝儿七3份,昂天莲鲜根10份,枇杷芋2份,炙甘草9份。
进一步的,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物35%,蜂蜡15%,白鹅膏15%,山茶油4%,玫瑰精油1.5%,药物发热剂3%,医用渗透剂3%,砭石粉23.5%;制成所述中药提取液物的原料组成及重量份数为:延胡索15份,丹参8份,鸡血藤9份,炮山甲9份,五灵脂6份,红花12份,艾叶15份,天仙藤11份,没药12份,马齿苋鲜品15份,乌梢蛇8份,珍珠12份,白鲜皮12份,地肤子10份,紫苏叶鲜品15份,金纳香6份,窝儿七5份,昂天莲鲜根15份,枇杷芋4份,炙甘草12份。
进一步的,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物30%,蜂蜡12%,白鹅膏13%,山茶油3%,玫瑰精油1%,药物发热剂2%,医用渗透剂2%,砭石粉37%;制成所述中药提取液物的原料组成及重量份数为:延胡索12份,丹参7份,鸡血藤8份,炮山甲7份,五灵脂5份,红花11份,艾叶12份,天仙藤10份,没药10份,马齿苋鲜品12份,乌梢蛇6份,珍珠10份,白鲜皮11份,地肤子8份,紫苏叶鲜品12份,金纳香5份,窝儿七4份,昂天莲鲜根12份,枇杷芋3份,炙甘草10份。
进一步的,所述砭石粉为50~80目砭石粉末,所述药用发热剂为医用辣椒素、香草醇丁醚的一种或多种,所述医用渗透剂为桉油、亚油酸、氮酮的一种或多种。
本发明还提供了所述的砭石泥灸的制备方法,包括以下步骤:
(1)制备中药提取物;
(2)蜂蜡、白鹅膏、山茶油、药物发热剂、医用渗透剂混合加热成液态,加入中药提取物、砭石粉末、玫瑰精油,混合搅拌均匀即得砭石泥灸。
进一步的,所述的砭石泥灸的制备方法,步骤(1)包括以下步骤:
1)丹参、鸡血藤、炮山甲、红花、艾叶、地肤子、金纳香、枇杷芋、炙甘草加入总质量倍数6倍的水浸泡1小时,文火煎煮1小时,煎煮后过200目过滤网得滤液,备用;
2)延胡索、五灵脂、天仙藤、没药、乌梢蛇、珍珠、白鲜皮、窝儿七用粉碎机粉碎至200目混合药粉,备用;
3)马齿苋鲜品、紫苏叶鲜品、昂天莲鲜根加入步骤1)所得滤液混合榨汁后静置1小时,过200目过滤网过滤,所得滤液浓缩烘干至相对密度为1.20±0.02(60℃)的浓缩液;
4)向步骤3)的浓缩液中加入步骤2)制得的混合药粉,混合均匀,得中药提取物。
本发明的砭石泥灸,以砭石费料磨成的砭石粉代替泥灸中常用的火山泥成分,相较于火山泥砭石粉具有更好的远红外和超声波疗效,在砭石的远红外线作用下,能使人体血管有节律的舒张和收缩,改善血管壁弹性,改善动脉硬化等症状,促进血液循环,调节脏腑经络之气,能更好地发挥通血脉的作用,并具有疏通经络、调理气血、活血化瘀、排除瘀浊邪毒、促进脏腑气血通畅,对于稳定血压有明显的效果;砭石通过远红外与超声波的双重作用,能够加速体液、血液的循环,提高皮肤的吸收能力;砭石的远红外线频谱,针对女性的痛经、月经失调等病症效果非常明显。与火山泥相比,砭石所含的矿物质元素更加丰富,砭石含有三十几种微量元素,其中锶的含量甚高,远远高于火山泥等其他矿物质泥,人的头发和皮肤中均含有锶,缺锶会导致头发变白,皮肤免疫力下降等问题,适当在皮外补充锶有助皮肤再生、修复细胞,促进皮肤新陈代谢,同时会提高皮肤抗氧化能力及免疫能力,帮助皮肤排出毒素,锶还可以起到皮外舒敏的作用,减少泥灸过程中产生的皮肤敏感症状。除了砭石粉外,该泥灸中中药提取物所含的有效成分针对痛经的成因可以起到活血化瘀、理气止痛的效果,调经养血从根本上治疗痛经的,有效缓解患者痛苦,同时充分考虑泥灸过程中易产生皮肤过敏症状的情况,合理加入舒敏生肌的有效成分,有效预防缓解皮肤敏感症状,所选原料配伍得当,其中:
延胡索:辛、苦、温,无毒,归肝、胃、心、肺、脾经,活血散瘀、理气止痛,主心腹腰膝诸痛、月经不调、症瘕、崩中、产后血晕、恶露不尽、跌打损伤;
丹参:味苦,微寒,活血祛瘀,通经止痛,清心除烦,凉血消痈,用于胸痹心痛,脘腹胁痛,瘕瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛;
鸡血藤:活血、舒筋,治腰膝酸痛,麻木瘫痪,月经不调,《现代实用中药》:“为强壮性之补血药,适用于贫血性之神经麻痹症,如肢体及腰膝酸痛,麻木不仁等。又用于妇女月经不调,月经闭止等,有活血镇痛之效。”;
炮山甲:消肿化脓、散淤通络、通经、下乳、活血镇痛,主治痈疽疮肿、风寒湿痹、经闭、乳汁不通、止血、症痂积聚;
五灵脂:甘,温,活血散瘀,炒炭止血,用于心腹淤血作痛,痛经,血瘀经闭,产后淤血腹痛,炒炭治崩漏下血;
红花:辛,温,入心、肝经,活血通经,去瘀止痛,治经闭,症瘕,难产,死胎,产后恶露不行、瘀血作痛,痈肿,跌扑损伤;
艾叶:苦辛,温,入脾、肝、肾经,理气血,逐寒湿,温经,止血,安胎,治心腹冷痛,泄泻转筋,久痢,吐衄,下血,月经不调,崩漏,带下,胎动不安,痈疡,疥癣;
天仙藤:苦,温,行气活血,利水消肿,用于脘腹刺痛,关节痹痛,妊娠水肿;
没药:味辛、苦,性平,散瘀定痛,消肿生肌,用于胸痹心痛,胃脘疼痛,痛经经闭.产后瘀阻,癥瘕腹痛,风湿痹痛,跌打损伤,痈肿疮疡等病症的治疗;
马齿苋:性寒,味甘酸,入心、肝、脾、大肠经,具有收湿止痒、清热消肿、清热解毒,利水去湿,散血消肿,除尘杀菌,消炎止痛,止血凉血的作用,马齿苋中含有丰富的具有特殊生物活性的氨基酸,对血管平滑肌有收缩作用,并且此种收缩作用兼有中枢及末梢性,可以起舒缓皮肤和止痒的作用,马齿苋中含有的生物碱和黄铜消炎作用,可以抑制皮肤红肿;
珍珠:镇心安神,养阴熄风,清热坠痰,去翳明目,解毒生肌,治惊悸,怔忡,癫痫,惊风搐搦,烦热消渴,喉痹口疳,目生翳障,疮疡久不收口;
乌梢蛇:甘,平,祛风,通络,止痉,用于风湿顽痹,麻木拘挛,中风口眼歪斜,半身不遂,抽搐痉挛,破伤风,麻风疥癣,瘰疬恶疮;
白鲜皮:苦,咸,寒,清热燥湿,祛风止痒,解毒,风热湿毒所致的风疹,湿疹,疥癣,黄疸,湿热痹;
地肤子:味辛、苦,性寒,清热利湿,祛风止痒,用于小便涩痛,阴痒带下,风疹,湿疹,皮肤瘙痒;
紫苏叶:紫苏叶为发生之物,辛温能散,气薄能通,味薄发泄,专解肌发表,疗伤风伤寒,及疟疾初起,外感霍乱,湿热脚气,凡属表症,放邪气出路之要药也,紫苏叶富含花青素,花青素是一种强有力的抗氧化剂,它能够保护人体免受自由基的损伤,花青素还能够增强血管弹性,改善血液循环系统和增进皮肤的光滑度,抑制炎症和过敏;
金纳香:甘,微辛,性温,活血行气,散瘀消肿,主有经不调,症积疼痛,跌打损伤;
窝儿七:苦,辛,性平,清热解毒,活血祛瘀,祛风除湿,主风湿痹痛,跌打损伤,月经不调,小腹疼痛,毒蛇咬伤,痈肿疮疖;
昂天莲鲜根:微苦,辛,平,通经活血,消肿止痛,主月经不调,疮疡疖肿,跌打损伤;
樟木:辛,温,祛风湿,行气血,利关节,治心腹胀痛,脚气,痛风,疥癣,跌打损伤;
枇杷芋:涩微苦,温,理气止痛,止咳化痰,消胀健胃,治腹胀,胃痛,疝气,劳伤咳嗽;
炙甘草:含有甘草甜素、甘草次酸、甘草多糖等多种化学成分,具有抗炎及抗变态反应作用,可调节机体免疫功能,抗肿瘤和止痛作用,因此炙甘草的主要功效是和中缓急,润肺,解毒,调和诸药;
该中药提取物中,以延胡索为君药,起活血化瘀、理气止痛之效,针对痛经的气血运行不畅,胞宫经血流通受碍的病因有效治疗该病;丹参、鸡血藤、炮山甲、五灵脂、红花、天仙藤、没药、马齿苋鲜品、乌梢蛇、珍珠、白鲜皮、地肤子、紫苏叶鲜品、金纳香、窝儿七、昂天莲鲜根、枇杷芋为佐,以增益君药药效,并起舒敏生肌之效,其中,丹参、鸡血藤、炮山甲、五灵脂、红花、天仙藤、没药、乌梢蛇、金纳香、窝儿七、昂天莲鲜根可增益君药活血化瘀之效,天仙藤、紫苏叶、金纳香、樟木、枇杷芋可增益君药理气止痛之效,与君药共同作用,可有效疏通气血,针对病因治疗痛经,同时有效缓解腹痛症状,佐药中没药、马齿苋、珍珠、乌梢蛇、白鲜皮、地肤子、紫苏叶还具有舒敏生肌的作用以增强皮肤抵抗力,有效缓解预防泥灸过程中可能产生的过敏症状;炙甘草为佐,起调和营卫,起温中散寒之效;艾叶为引,可引药达少腹部,使药物有效成分直达患处,充分发挥作用。
除了砭石粉和中药提取物外,本发明的砭石泥灸所选用的辅料也具有很好的作用疗效,白鹅膏味甘,性凉,润皮肤,解毒肿,主皮肤皴裂,耳聋,聤耳,噎膈反胃,药物中毒,痈肿,疥癣,可以起到很好的护肤效果;玫瑰精油具有抗菌、抗痉挛、杀菌、净化、镇静等功效,适用所有肤质犹其是成熟干燥或敏感,任何敏感红肿和发炎皮肤,玫瑰精油有强壮和收缩微血管的效果,对皮肤具有很好的保护作用,可以增强中药提取物的有效成分和砭石的舒敏效果,进一步预防皮肤过敏,同时玫瑰精油芳香宜人,可以很好的掩盖中药的气味,使患者在整个治疗过程中心情更加舒缓愉悦,精神更加放松,有利于增进治疗效果;山茶油营养丰富,含脂肪酸(不饱和脂肪酸93%,其中油酸82%,亚油酸11%)、山茶甙、茶多酚、皂甙、鞣质,及富含抗氧化剂和具有消炎功效的角鲨烯,角鲨烯与黄酮类物质,对抗癌有着极佳的作用,角鲨烯有助于保持皮肤的柔软健康,它是一种抗氧化剂,可有效改善皮肤色泽,对人类免疫系统有神奇疗效,其抗氧化作用可以在恶劣环境下,有效保护皮肤。
本发明的有益效果为:本发明弥补了现有技术不足,提供了一种砭石泥灸及其制备方法,该泥灸以砭石下脚料制成的砭石粉代替火山泥成分,配合针对性治疗痛经的中药提取物,可起到安全有效治疗痛经的作用,有效防止皮肤敏感症状,同时可以合理的利用砭石废料,变废为宝。具体而言:
(1)本发明以砭石费料磨成的砭石粉代替泥灸中常用的火山泥成分,充分利用了砭石废料,同时,相较于火山泥砭石粉具有更好的远红外和超声波疗效,在砭石的远红外线作用下,能使人体血管有节律的舒张和收缩,改善血管壁弹性,改善动脉硬化等症状,促进血液循环,调节脏腑经络之气,能更好地发挥通血脉的作用,并具有疏通经络、调理气血、活血化瘀、排除瘀浊邪毒、促进脏腑气血通畅,对于稳定血压有明显的效果;砭石通过远红外与超声波的双重作用,能够加速体液、血液的循环,提高皮肤的吸收能力,促进其他有效成分的透皮吸收,促进药效的发挥;砭石的远红外线频谱,针对女性的痛经、月经失调等病症效果非常明显。与火山泥相比,砭石所含的矿物质元素更加丰富,砭石含有三十几种微量元素,其中锶的含量甚高,远远高于火山泥等其他矿物质泥,人的头发和皮肤中均含有锶,缺锶会导致头发变白,皮肤免疫力下降等问题,适当在皮外补充锶有助皮肤再生、修复细胞,促进皮肤新陈代谢,同时会提高皮肤抗氧化能力及免疫能力,帮助皮肤排出毒素,锶还可以起到皮外舒敏的作用,减少泥灸过程中产生的皮肤敏感症状。
(2)本发明的中药提取物,采取先进制药技术充分有效提取原料中的有效成分,所选原料配伍得当,共奏活血化瘀、理气止痛之效,有效缓解腹痛症状,调节疏通气血,根治痛经,同时,原料中的没药、马齿苋、珍珠、乌梢蛇、白鲜皮、地肤子、紫苏叶可以起到舒敏生肌的作用,如紫苏叶富含花青素,花青素是一种强有力的抗氧化剂,它能够保护人体免受自由基的损伤,花青素还能够增强血管弹性,改善血液循环系统和增进皮肤的光滑度,抑制炎症和过敏,马齿苋中含有丰富的具有特殊生物活性的氨基酸,对血管平滑肌有收缩作用,并且此种收缩作用兼有中枢及末梢性,可以起舒缓皮肤和止痒的作用,马齿苋中含有的生物碱和黄铜消炎作用,可以抑制皮肤红肿;这些药物有效成分与砭石粉、白鹅膏、山茶油、玫瑰精油共同作用,可有效预防缓解泥灸过程中的皮肤敏感症状。
(3)优选方案中,采用50-80目的砭石粉作为原料,使所得泥灸的质地较为粗糙,涂敷在皮肤上所形成的涂层会产生较大的孔隙,可以起到透气、透湿的作用,减少过敏症状。
具体实施方式
根据下述实施例,可以更好地理解本发明。然而,本领域的技术人员容易理解,实施例所描述的具体的物料配比、工艺条件及其结果仅用于说明本发明而不应当也不会限制权利要求书中所详细描述的本发明。
实施例1
一种砭石泥灸,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物25%,蜂蜡10%,白鹅膏10%,山茶油2%,玫瑰精油0.5%,药物发热剂1.5%,医用渗透剂1.5%,砭石粉49.5%;制成所述中药提取液物的原料组成及重量份数为:延胡索9份,丹参6份,鸡血藤6份,炮山甲6份,五灵脂4份,红花9份,艾叶10份,天仙藤8份,没药8份,马齿苋鲜品10份,乌梢蛇5份,珍珠8份,白鲜皮9份,地肤子7份,紫苏叶鲜品10份,金纳香4份,窝儿七3份,昂天莲鲜根10份,枇杷芋2份,炙甘草9份,所述砭石粉为50目砭石粉末,所述药用发热剂为香草醇丁醚,所述医用渗透剂为桉油。
所述的砭石泥灸的制备方法,包括以下步骤:
(1)丹参、鸡血藤、炮山甲、红花、艾叶、地肤子、金纳香、枇杷芋、炙甘草加入总质量倍数6倍的水浸泡1小时,文火煎煮1小时,煎煮后过200目过滤网得滤液,备用;
(2)延胡索、五灵脂、天仙藤、没药、乌梢蛇、珍珠、白鲜皮、窝儿七用粉碎机粉碎至200目混合药粉,备用;
(3)马齿苋鲜品、紫苏叶鲜品、昂天莲鲜根加入步骤(1)所得滤液混合榨汁后静置1小时,过200目过滤网过滤,所得滤液浓缩烘干至相对密度为1.20±0.02(60℃)的浓缩液;
(4)向步骤(3)的浓缩液中加入步骤(2)制得的混合药粉,混合均匀,得中药提取物。
(5)蜂蜡、白鹅膏、山茶油、药物发热剂、医用渗透剂混合加热成液态,加入步骤(4)所得的中药提取物、砭石粉末、玫瑰精油,混合搅拌均匀即得砭石泥灸。
实施例2
一种砭石泥灸,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物35%,蜂蜡15%,白鹅膏15%,山茶油4%,玫瑰精油1.5%,药物发热剂3%,医用渗透剂3%,砭石粉23.5%;制成所述中药提取液物的原料组成及重量份数为:延胡索15份,丹参8份,鸡血藤9份,炮山甲9份,五灵脂6份,红花12份,艾叶15份,天仙藤11份,没药12份,马齿苋鲜品15份,乌梢蛇8份,珍珠12份,白鲜皮12份,地肤子10份,紫苏叶鲜品15份,金纳香6份,窝儿七5份,昂天莲鲜根15份,枇杷芋4份,炙甘草12份,所述砭石粉为80目砭石粉末,所述药用发热剂为医用辣椒素,所述医用渗透剂为氮酮。
实施例2的砭石泥灸的制备方法与实施例1相同。
实施例3
一种砭石泥灸,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物30%,蜂蜡12%,白鹅膏13%,山茶油3%,玫瑰精油1%,药物发热剂2%,医用渗透剂2%,砭石粉37%;制成所述中药提取液物的原料组成及重量份数为:延胡索12份,丹参7份,鸡血藤8份,炮山甲7份,五灵脂5份,红花11份,艾叶12份,天仙藤10份,没药10份,马齿苋鲜品12份,乌梢蛇6份,珍珠10份,白鲜皮11份,地肤子8份,紫苏叶鲜品12份,金纳香5份,窝儿七4份,昂天莲鲜根12份,枇杷芋3份,炙甘草10份,所述砭石粉为60目砭石粉末,所述药用发热剂为香草醇丁醚,所述医用渗透剂为亚油酸。
实施例3的砭石泥灸的制备方法与实施例1相同。
实施例4过敏试验
取健康白色豚鼠18只,体重250-300g,雌雄兼用,试验前剔除两侧背毛,每侧3×3cm,随机分为试验组、空白对照组和阳性对照组,阳性对照组用2,4-二硝基氯苯,致敏用1%浓度,激发用0.1%浓度;试验组用本发明实施例2的砭石泥灸,涂抹前将该产品用微波炉中高火加热3分钟至完成融化后,降温至42±3℃后涂敷。取本发明实施例2的砭石泥灸涂于背部去毛区,隔日1次,共3次。于末次接触后14天,在背部同一区域涂抹该产品,6h后去除药品后即刻观察,并于24、48、72h观察有无过敏反应。空白对照组和阳性对照组用同法激发接触和观察。试验结果:阳性对照组动物皮肤在致敏1小时后即出现局限性红斑和轻微水肿,24小时过敏反应症状加重,致敏率为100%,试验组和空白对照组动物皮肤均未出现任何过敏反应症状,致敏率为0%。实验结果表明本发明的中药泥灸配方温和无刺激,无过敏症状。
实施例5临床资料
本发明用于治疗痛经患者400例进行临床观察治疗。其中年龄最小者15岁,最大者45岁,平均年龄24岁,病程5个月—26年。诊断标准为患者经期前后或行经期间,出现下腹部痉挛性疼痛,并有全身不适,严重影响患者的日常生活,均确诊患有痛经症。患者随机均分为4组,分别试用本发明实施例1至3和对照组的泥灸治疗痛经,使用方法为将泥灸用微波炉加热至完全融化后自然冷却至40℃左右,涂敷于患者腹部,30分钟后换掉,每天一次,5个月为一个疗程,评价其治疗痛经的效果,并观察患者有无皮肤瘙痒、红肿等过敏症状,疗效评定标准为:
痊愈:疼痛消失,连续3个月经周期末见复发;
好转:疼痛减轻或疼痛消失,但不能维持3个月以上;
无效:疼痛末见改善。
对照组泥灸的配方和制备方法如下:
对照组泥灸的组分配方及其质量百分百为:中药提取物25%,蜂蜡10%,白鹅膏10%,山茶油2%,玫瑰精油0.5%,药物发热剂1.5%,医用渗透剂1.5%,火山泥49.5%,制成所述中药提取液物的原料组成及重量份数为:延胡索9份,丹参6份,鸡血藤6份,炮山甲6份,五灵脂4份,红花9份,艾叶10份,天仙藤8份,没药8份,马齿苋鲜品10份,乌梢蛇5份,珍珠8份,白鲜皮9份,地肤子7份,紫苏叶鲜品10份,金纳香4份,窝儿七3份,昂天莲鲜根10份,枇杷芋2份,炙甘草9份,所述砭石粉为50目砭石粉末,所述药用发热剂为香草醇丁醚,所述医用渗透剂为桉油。
其制备方法,包括以下步骤:
(1)丹参、鸡血藤、炮山甲、红花、艾叶、地肤子、金纳香、枇杷芋、炙甘草加入总质量倍数6倍的水浸泡1小时,文火煎煮1小时,煎煮后过200目过滤网得滤液,备用;
(2)延胡索、五灵脂、天仙藤、没药、乌梢蛇、珍珠、白鲜皮、窝儿七用粉碎机粉碎至200目混合药粉,备用;
(3)马齿苋鲜品、紫苏叶鲜品、昂天莲鲜根加入步骤(1)所得滤液混合榨汁后静置1小时,过200目过滤网过滤,所得滤液浓缩烘干至相对密度为1.20±0.02(60℃)的浓缩液;
(4)向步骤(3)的浓缩液中加入步骤(2)制得的混合药粉,混合均匀,得中药提取物。
(5)蜂蜡、白鹅膏、山茶油、药物发热剂、医用渗透剂混合加热成液态,加入步骤(4)所得的中药提取物、火山泥、玫瑰精油,混合搅拌均匀即得对照组泥灸。
治疗结果统计如下表:
经5个月的治疗后,本发明的砭石泥灸的总有效率高达92%以上,明显高于以火山泥作为原料的对照组泥灸的疗效(有效率75%),实施例1至3的砭石泥灸的致敏率均为零,明显优于对照组12%的致敏率,证明本发明的砭石泥灸用于治疗痛经疗效显著,安全有效,且使用砭石粉代替火山泥制作该泥灸可以起到更好的疗效,且不易产生皮肤过敏症状。
典型病例
张某,25岁,每次月经来的前几天总是腹部疼痛难忍,需服药止痛药止痛,月经量特别少,经多方治疗效果不明显,后使用本发明实施例1的砭石泥灸,一个疗程后,腹痛症状明显减轻,连续使用2个疗程后,每次来月经,月经量正常,腹痛症状消失,停止泥灸后,随访5个月无复发。
王某某,28岁,经期痉挛性腹痛、腰痛,恶心、呕吐,月经量多带有紫色血块,周期紊乱,病史12年。使用本发明实施例2的砭石泥灸,一个疗程后,腹痛、腰痛、恶心、呕吐症状明显减轻,周期基本稳定,经血量和颜色基本正常,无血块,连续使用2个疗程后痊愈,停止泥灸后,随访5个月无复发。
曲某,19岁,经期痉挛性腹痛、恶心、呕吐、低烧,月经量多,病史4年。使用本发明实施例3的砭石泥灸,一个疗程后,腹痛、恶心、呕吐症状明显减轻,低烧症状消失,月经量基本正常,无血块,连续使用2个疗程后痊愈,停止泥灸后,随访5个月无复发。
以上实施方式只为说明本发明的技术构思及特点,其目的在于让熟悉此项技术的人了解本发明内容并加以实施,并不能以此限制本发明的保护范围,凡根据本发明精神实质所做的等效变化或修饰,都应涵盖在本发明的保护范围内。
Claims (7)
1.一种砭石泥灸,其特征是,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物25%~35%,蜂蜡10%~15%,白鹅膏10%~15%,山茶油2%~4%,玫瑰精油0.5%~1.5%,药物发热剂1.5%~3%,医用渗透剂1.5%~3%,余量为砭石粉;制成所述中药提取液物的原料组成及重量份数为:延胡索9-15份,丹参6-8份,鸡血藤6-9份,炮山甲6-9份,五灵脂4-6份,红花9-12份,艾叶10-15份,天仙藤8-11份,没药8-12份,马齿苋鲜品10-15份,乌梢蛇5-8份,珍珠8-12份,白鲜皮9-12份,地肤子7-10份,紫苏叶鲜品10-15份,金纳香4-6份,窝儿七3-5份,昂天莲鲜根10-15份,枇杷芋2-4份,炙甘草9-12份。
2.如权利要求1所述的一种砭石泥灸,其特征是,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物25%,蜂蜡10%,白鹅膏10%,山茶油2%,玫瑰精油0.5%,药物发热剂1.5%,医用渗透剂1.5%,砭石粉49.5%;制成所述中药提取液物的原料组成及重量份数为:延胡索9份,丹参6份,鸡血藤6份,炮山甲6份,五灵脂4份,红花9份,艾叶10份,天仙藤8份,没药8份,马齿苋鲜品10份,乌梢蛇5份,珍珠8份,白鲜皮9份,地肤子7份,紫苏叶鲜品10份,金纳香4份,窝儿七3份,昂天莲鲜根10份,枇杷芋2份,炙甘草9份。
3.如权利要求1所述的一种砭石泥灸,其特征是,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物35%,蜂蜡15%,白鹅膏15%,山茶油4%,玫瑰精油1.5%,药物发热剂3%,医用渗透剂3%,砭石粉23.5%;制成所述中药提取液物的原料组成及重量份数为:延胡索15份,丹参8份,鸡血藤9份,炮山甲9份,五灵脂6份,红花12份,艾叶15份,天仙藤11份,没药12份,马齿苋鲜品15份,乌梢蛇8份,珍珠12份,白鲜皮12份,地肤子10份,紫苏叶鲜品15份,金纳香6份,窝儿七5份,昂天莲鲜根15份,枇杷芋4份,炙甘草12份。
4.如权利要求1所述的一种砭石泥灸,其特征是,组成所述砭石泥灸的组分配方及其质量百分百为:中药提取物30%,蜂蜡12%,白鹅膏13%,山茶油3%,玫瑰精油1%,药物发热剂2%,医用渗透剂2%,砭石粉37%;制成所述中药提取液物的原料组成及重量份数为:延胡索12份,丹参7份,鸡血藤8份,炮山甲7份,五灵脂5份,红花11份,艾叶12份,天仙藤10份,没药10份,马齿苋鲜品12份,乌梢蛇6份,珍珠10份,白鲜皮11份,地肤子8份,紫苏叶鲜品12份,金纳香5份,窝儿七4份,昂天莲鲜根12份,枇杷芋3份,炙甘草10份。
5.如权利要求1至4任一项所述的一种砭石泥灸,其特征是,所述砭石粉为50~80目砭石粉末,所述药用发热剂为医用辣椒素、香草醇丁醚的一种或多种,所述医用渗透剂为桉油、亚油酸、氮酮的一种或多种。
6.如权利要求1至5任一项所述的砭石泥灸的制备方法,其特征在于,包括以下步骤:
(1)制备中药提取物;
(2)蜂蜡、白鹅膏、山茶油、药物发热剂、医用渗透剂混合加热成液态,
加入中药提取物、砭石粉末、玫瑰精油,混合搅拌均匀即得砭石泥灸。
7.如权利要求6所述的砭石泥灸的制备方法,其特征在于,所述步骤(1)包括以下步骤:
1)丹参、鸡血藤、炮山甲、红花、艾叶、地肤子、金纳香、枇杷芋、炙甘草加入总质量倍数6倍的水浸泡1小时,文火煎煮1小时,煎煮后过200目过滤网得滤液,备用;
2)延胡索、五灵脂、天仙藤、没药、乌梢蛇、珍珠、白鲜皮、窝儿七用粉碎机粉碎至200目混合药粉,备用;
3)马齿苋鲜品、紫苏叶鲜品、昂天莲鲜根加入步骤1)所得滤液混合榨汁后静置1小时,过200目过滤网过滤,所得滤液浓缩烘干至相对密度为1.20±0.02(60℃)的浓缩液;
4)向步骤3)的浓缩液中加入步骤2)制得的混合药粉,混合均匀,得中药提取物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610093807.3A CN105687409A (zh) | 2016-02-19 | 2016-02-19 | 一种砭石泥灸及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610093807.3A CN105687409A (zh) | 2016-02-19 | 2016-02-19 | 一种砭石泥灸及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105687409A true CN105687409A (zh) | 2016-06-22 |
Family
ID=56223020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610093807.3A Pending CN105687409A (zh) | 2016-02-19 | 2016-02-19 | 一种砭石泥灸及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105687409A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106333984A (zh) * | 2016-09-26 | 2017-01-18 | 田忠新 | 灸粉及其制备方法 |
CN106726494A (zh) * | 2016-12-22 | 2017-05-31 | 云南贝洋生物科技有限公司 | 一种灸疗器 |
CN110200804A (zh) * | 2019-07-15 | 2019-09-06 | 刘东泰 | 一种玉石茶灸组合物及其制备方法 |
CN111701387A (zh) * | 2020-06-24 | 2020-09-25 | 深圳金田弘科技开发有限公司 | 一种光灸烟盒及其制备方法 |
CN114344283A (zh) * | 2021-12-08 | 2022-04-15 | 李强斌 | 具有温胃散寒作用的自发热中药蜡泥贴及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2385271A1 (en) * | 2002-05-22 | 2003-11-22 | Chen Wang | The powder for the root-cultivation, elimination of disaster and longevity |
CN103191247A (zh) * | 2013-04-28 | 2013-07-10 | 王晓杰 | 用于砭石熨烫灸的中药药袋 |
-
2016
- 2016-02-19 CN CN201610093807.3A patent/CN105687409A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2385271A1 (en) * | 2002-05-22 | 2003-11-22 | Chen Wang | The powder for the root-cultivation, elimination of disaster and longevity |
CN103191247A (zh) * | 2013-04-28 | 2013-07-10 | 王晓杰 | 用于砭石熨烫灸的中药药袋 |
Non-Patent Citations (1)
Title |
---|
明荷等: "药泥灸治疗寒凝血瘀型原发性痛经的临床观察", 《中国民间疗法》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106333984A (zh) * | 2016-09-26 | 2017-01-18 | 田忠新 | 灸粉及其制备方法 |
CN106726494A (zh) * | 2016-12-22 | 2017-05-31 | 云南贝洋生物科技有限公司 | 一种灸疗器 |
CN110200804A (zh) * | 2019-07-15 | 2019-09-06 | 刘东泰 | 一种玉石茶灸组合物及其制备方法 |
CN111701387A (zh) * | 2020-06-24 | 2020-09-25 | 深圳金田弘科技开发有限公司 | 一种光灸烟盒及其制备方法 |
CN114344283A (zh) * | 2021-12-08 | 2022-04-15 | 李强斌 | 具有温胃散寒作用的自发热中药蜡泥贴及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104958484A (zh) | 一种活血通络的中药膏及其制备方法 | |
CN104147577A (zh) | 一种用于促进骨痂生长治疗骨折的膏药 | |
CN105687409A (zh) | 一种砭石泥灸及其制备方法 | |
CN103520461B (zh) | 一种用于治疗过敏性鼻炎的药物 | |
CN103463500B (zh) | 一种治疗脑出血的药物 | |
CN101181568B (zh) | 一种治骨质增生及关节疼痛的中药制剂 | |
CN103877247B (zh) | 用于治疗褥疮的药物及其制备方法 | |
CN103933498A (zh) | 一种治疗慢性萎缩性胃炎的药物及制备方法 | |
CN104069162A (zh) | 一种治疗痛风性关节炎及各种骨关节疼痛的中药 | |
CN102671070A (zh) | 一种治疗癌症或肿瘤的中药组合物 | |
CN103432269B (zh) | 一种治疗放射性肠炎的中药制剂 | |
CN101204494B (zh) | 一种治疗慢性肠炎的药物 | |
CN103393943A (zh) | 一种治疗脑梗塞后遗症的中药组合物 | |
CN103623111B (zh) | 一种治疗荨麻疹的中药 | |
CN106177639A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN102416049B (zh) | 一种小方型风湿消肿消痛膏药 | |
CN104825598A (zh) | 一种治疗风湿骨痛的外用膏药及其制备方法 | |
CN104984280A (zh) | 一种治疗外感风寒的泡脚汤及其制备方法 | |
CN104055900A (zh) | 一种治疗荨麻疹的中药组合物 | |
CN103735950A (zh) | 一种用于防治痔疮的中药组合物及其制备方法 | |
CN104083456B (zh) | 一种治疗荨麻疹的中药汤剂 | |
CN102872210B (zh) | 一种治疗荨麻疹的中药 | |
CN102935191B (zh) | 一种用于坐骨神经痛的药物及制备方法 | |
CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
CN105535344A (zh) | 一种治疗气滞血瘀所致的乳腺小叶增生的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160622 |